Zum Inhalt springen
← Aellic Evidenz

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach et al. · 2020 · European Heart Journal 41(1):111-188

What this work gives Aellic

European guideline that sets LDL cholesterol goals by cardiovascular risk (below 3.0 mmol/l, 116 mg/dl, may be considered at low risk) and sets no triglyceride goal, but treats triglycerides below 1.7 mmol/l (150 mg/dl) as lower risk.

Correction of 25 October 2026

The registry named this guideline as a source of the generic non-HDL line of 150 mg/dl. It sets none: its non-HDL goals are secondary and start at moderate risk (below 3.4 mmol/l, 130 mg/dl). The non-HDL line now cites nordestgaard2016.

The entry on the register was wrong. It was not replaced but kept, with what holds instead standing next to it.

Where this sits in the engine

This work is on the register, but nothing computes with it today, mostly because the feature it belongs to has not been built yet. It is listed so the numbers on the overview do not claim more than they carry.